EXAM QUESTIONS AND CORRECT
ANSWERS ALREADY A+ GRADED|
UPDATE|BRAND NEW!!
Save
Terms in this set (72)
- Screen for mental health issues
- Improve outcomes and reduce
health care costs
What is the role - Assess and give care to mild-
of the primary moderate disorders or patients with
care provider in stable severe mental disorders
mental health? - From strong links with mental
health specialty care for complex
cases
Sharing patient info (ex: meds used)
, - Screens for MDD
- It is the first two questions of the
PHQ9
- In the last two week, have you
been feeling these (not at all,
several days, more than half the day,
about PHQ2 nearly everyday):
- what does it - Little interest or pleasure in doing
screen for, what things?
are the - Feeling down, depressed, or
questions, hopeless?
scoring
Scoring:
A single yes or score >3 (out of 0-6)
= possible clinical depression ⇒ due
the PHQ9
If the pt screens (+) ⇒ continue to
eval with the PHQ9
, Used for screening, diagnosing, and
treating
- It asks about functioning
impairments which is needed for the
DSM-based diagnosis
Includes asking about suicide or
hurting self
Scoring:
0-27 available
about PHQ9 0-4: Minimal/none
- what its used Monitor; may not require treatment
for, questions, 5-9: Mild
scoring Use clinical judgment; follow-up in
one month
10-14: Moderate
Use clinical judgment; may need
meds if functionally impaired
15-19: Moderately Severe
Warrants active treatment with
psychotherapy, meds, or combo
20-27: Severe
Warrants active treatment with
psychotherapy, meds, or combo
, What is the 20mg PO once daily in the AM
appropriate - May ↑ daily dose after several
initiation dose weeks if inadequate response
for fluoxetine for - Full therapeutic effect may be
adults and delayed 4 weeks or longer
geriatric adults? - Max dose: 80mg/day
Sodium levels
- Baseline screening & after 3-4
What labs would
weeks in high-risk patients (> 65yrs,
be appropriate
previous hx of antidepressant-
to draw if you
induced hyponatremia, low body
initiate fluoxetine
weight, concomitant use of thiazides
in a geriatric
or other hyponatremia-inducing
patient?
agents)
- monitor regularly in the elderly